Cboe UK CHF

Medartis Holding AG (MEDZ.XC)

Compare
65.00
-2.60
(-3.85%)
At close: 4:00:37 PM GMT
Currency in CHF All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
212,006.00
212,006.00
182,824.00
159,880.24
127,645.99
Cost of Revenue
44,434.00
44,434.00
33,335.00
25,772.74
21,150.78
Gross Profit
167,572.00
167,572.00
149,489.00
134,107.49
106,495.21
Operating Expense
157,895.00
157,895.00
151,359.00
123,093.59
103,396.02
Operating Income
9,677.00
9,677.00
-1,870.00
11,013.91
3,099.19
Net Non Operating Interest Income Expense
-2,756.00
-2,756.00
-2,035.00
-1,333.97
-1,004.16
Pretax Income
1,794.00
1,794.00
-7,145.00
8,289.63
-3,264.18
Tax Provision
1,174.00
1,174.00
-1,362.00
1,451.76
-2,320.61
Net Income Common Stockholders
619.00
619.00
-5,783.00
6,837.87
-943.57
Diluted NI Available to Com Stockholders
619.00
619.00
-5,783.00
6,837.87
-943.57
Basic EPS
0.05
0.05
-0.49
0.58
-0.08
Diluted EPS
0.05
0.05
-0.49
0.58
-0.08
Basic Average Shares
12,231.88
12,231.88
11,834.47
11,800.70
11,768.94
Diluted Average Shares
12,231.88
12,231.88
11,834.47
11,800.70
11,768.94
Total Operating Income as Reported
9,104.00
9,104.00
-1,922.00
11,056.43
3,131.43
Total Expenses
202,329.00
202,329.00
184,694.00
148,866.33
124,546.79
Net Income from Continuing & Discontinued Operation
619.00
619.00
-5,783.00
6,837.87
-943.57
Normalized Income
619.00
619.00
-5,783.00
6,837.87
-943.57
Interest Income
337.00
337.00
250.00
135.31
365.29
Interest Expense
828.00
828.00
734.00
754.01
776.71
Net Interest Income
-2,756.00
-2,756.00
-2,035.00
-1,333.97
-1,004.16
EBIT
2,622.00
2,622.00
-6,411.00
9,043.64
-2,487.46
EBITDA
25,383.00
25,383.00
11,701.00
25,430.38
13,401.50
Reconciled Cost of Revenue
44,434.00
44,434.00
33,335.00
25,772.74
21,150.78
Reconciled Depreciation
22,761.00
22,761.00
18,112.00
16,386.74
15,888.97
Net Income from Continuing Operation Net Minority Interest
619.00
619.00
-5,783.00
6,837.87
-943.57
Normalized EBITDA
25,383.00
25,383.00
11,701.00
25,430.38
13,401.50
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 4/4/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade